Viewing Study NCT00477750


Ignite Creation Date: 2025-12-24 @ 5:17 PM
Ignite Modification Date: 2026-02-22 @ 2:47 PM
Study NCT ID: NCT00477750
Status: COMPLETED
Last Update Posted: 2019-10-11
First Post: 2007-05-23
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Melphalan, Prednisone, and Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
Sponsor: Mayo Clinic
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma and Plasma Cell Neoplasm View
Keywords:

Keywords

Keyword Brief Keyword Text View
None stage III multiple myeloma View
None stage I multiple myeloma View
None stage II multiple myeloma View